Effects of Rituximab on Morphofunctional Abnormalities of Membranous Glomerulopathy | Zendy

Piero Ruggenenti | Zendy; Paolo Cravedi | Zendy; Maria Chiara Sghirlanzoni | Zendy; Elena Gagliardini | Zendy; Sara Conti | Zendy; Flavio Gaspari | Zendy; Gianfranco Marchetti | Zendy; Mauro Abbate | Zendy; Giuseppe Remuzzi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Rituximab on Morphofunctional Abnormalities of Membranous Glomerulopathy

Author(s) -

Piero Ruggenenti,

Paolo Cravedi,

Maria Chiara Sghirlanzoni,

Elena Gagliardini,

Sara Conti,

Flavio Gaspari,

Gianfranco Marchetti,

Mauro Abbate,

Giuseppe Remuzzi

Publication year - 2008

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.01730408

Subject(s) - medicine , renal function , interquartile range , rituximab , urology , gastroenterology , nephrotic syndrome , membranous nephropathy , benazepril , nephropathy , renal biopsy , pathology , endocrinology , kidney , glomerulonephritis , blood pressure , lymphoma , diabetes mellitus

In idiopathic membranous nephropathy (IMN), CD(20) B-cell depletion by rituximab may induce nephrotic syndrome (NS) remission. Whether this is associated with kidney function restoration and regression of the glomerular pathology was evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research